Vaxart Inc (VXRT)
0.7383
-0.03
(-4.04%)
USD |
NASDAQ |
May 07, 16:00
0.7383
0.00 (0.00%)
After-Hours: 17:30
Vaxart Market Cap: 128.36M for May 7, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 06, 2024 | 133.77M |
May 03, 2024 | 126.73M |
May 02, 2024 | 130.22M |
May 01, 2024 | 121.81M |
April 30, 2024 | 124.26M |
April 29, 2024 | 124.02M |
April 26, 2024 | 123.39M |
April 25, 2024 | 114.47M |
April 24, 2024 | 123.39M |
April 23, 2024 | 129.60M |
April 22, 2024 | 132.57M |
April 19, 2024 | 131.37M |
April 18, 2024 | 146.44M |
April 17, 2024 | 150.58M |
April 16, 2024 | 155.50M |
April 15, 2024 | 158.06M |
April 12, 2024 | 158.23M |
April 11, 2024 | 180.82M |
April 10, 2024 | 175.60M |
April 09, 2024 | 180.82M |
April 08, 2024 | 187.77M |
April 05, 2024 | 187.77M |
April 04, 2024 | 196.46M |
April 03, 2024 | 213.85M |
April 02, 2024 | 215.59M |
Date | Value |
---|---|
April 01, 2024 | 226.02M |
March 28, 2024 | 226.02M |
March 27, 2024 | 224.28M |
March 26, 2024 | 212.11M |
March 25, 2024 | 213.85M |
March 22, 2024 | 219.07M |
March 21, 2024 | 213.85M |
March 20, 2024 | 215.59M |
March 19, 2024 | 201.68M |
March 18, 2024 | 201.68M |
March 15, 2024 | 187.77M |
March 14, 2024 | 191.25M |
March 13, 2024 | 196.46M |
March 12, 2024 | 198.20M |
March 11, 2024 | 199.94M |
March 08, 2024 | 206.90M |
March 07, 2024 | 192.99M |
March 06, 2024 | 202.55M |
March 05, 2024 | 204.24M |
March 04, 2024 | 206.77M |
March 01, 2024 | 210.99M |
February 29, 2024 | 205.93M |
February 28, 2024 | 218.59M |
February 27, 2024 | 214.37M |
February 26, 2024 | 207.62M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.657M
Minimum
Sep 26 2019
2.573B
Maximum
Feb 02 2021
400.61M
Average
207.30M
Median
Market Cap Benchmarks
Novavax Inc | 644.48M |
aTyr Pharma Inc | 116.63M |
Allogene Therapeutics Inc | 492.06M |
AIM ImmunoTech Inc | 21.23M |
Protalix BioTherapeutics Inc | 82.91M |
Market Cap Related Metrics
PS Ratio | 11.53 |
Price to Book Value | 2.221 |
Price | 0.7383 |
Earnings Yield | -78.56% |